SPARCtool Updated to version 6.1

Release Notes

version 6.1 release notes

  • edited mobile/standard links to map to new site
  • edited sparcnotes links to map to new site and completely rewrote and reorganized SPARCtool Notes
  • fixed date field width on regular version
  • updated CHADS2 and CHA2DS2-VASc risk estimates to use BMJ 2011;342:d124, 10 year followup estimates.
  • upated all the CHADS2 risk descriptors to match the CHADS-VASc one based on BMJ 2011;342:d124, which is paraphrased as "ischemic stroke+thromboembolism"
  • updated warfarin population average major bleeding risk from 2.6 to 3.8%/year based on CMAJ November 26, 2012 cmaj.121218
  • add a reference for bleeding risk CPR vs. clinician judgement
  • added a warning for dabigatran, rivaroxaban, apixaban if "abnormal renal function" is checked in HAS-BLED
  • added a disclaimer to top of both tools